Penumbral Imaging-Based Thrombolysis with Tenecteplase Is Feasible up to 24 Hours after Symptom Onset.

about

Penumbral Imaging-Based Thrombolysis with Tenecteplase Is Feasible up to 24 Hours after Symptom Onset.

Item

http://www.wikidata.org/entity/Q50062348

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Penumbral Imaging-Based Thromb ...... 24 Hours after Symptom Onset.

@en

Penumbral Imaging-Based Thromb ...... 24 Hours after Symptom Onset.

@nl

type

Item

label

Penumbral Imaging-Based Thromb ...... 24 Hours after Symptom Onset.

@en

Penumbral Imaging-Based Thromb ...... 24 Hours after Symptom Onset.

@nl

prefLabel

Penumbral Imaging-Based Thromb ...... 24 Hours after Symptom Onset.

@en

Penumbral Imaging-Based Thromb ...... 24 Hours after Symptom Onset.

@nl

P1476

Penumbral Imaging-Based Thromb ...... o 24 Hours after Symptom Onset

@en

P2093

Ashfaq Shuaib

http://www.w3.org/2001/XMLSchema#string

Derek Emery

http://www.w3.org/2001/XMLSchema#string

Harsha Kamble

http://www.w3.org/2001/XMLSchema#string

Laura C Gioia

http://www.w3.org/2001/XMLSchema#string

Mahesh Kate

http://www.w3.org/2001/XMLSchema#string

Parnian Riaz

http://www.w3.org/2001/XMLSchema#string

Penelope Smyth

http://www.w3.org/2001/XMLSchema#string

Robert Wannamaker

http://www.w3.org/2001/XMLSchema#string

Thomas Jeerakathil

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

Reperfusion therapies for wake-up stroke: systematic review

A randomized trial of tenecteplase versus alteplase for acute ischemic stroke

Perfusion computed tomography to assist decision making for stroke thrombolysis

Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial

A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke.

Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice: retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trials.

Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.

Stroke code improves intravenous thrombolysis administration in acute ischemic stroke

A faster-acting and more potent form of tissue plasminogen activator.

P304

122-130

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5853/JOS.2017.00178

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Brian Buck

Ken Butcher

P577

2018-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29402060

http://www.w3.org/2001/XMLSchema#string

P921

thrombolysis

P932

5836582

http://www.w3.org/2001/XMLSchema#string